| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc. (ALLO) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. ALLO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 1.28M | $2.96M | - | |
| VP | 217.7K | $505.1K | - | |
| Dir | 144.4K | $335.0K | - | |
| Dir | 95.4K | $221.3K | - | |
| Dir | 95.4K | $221.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Beneski Benjamin MacHinas | SVP, Chief Technical Officer | Sell | 786 | $1.22 | $958.92 | -0.4% | +75.6% | - | |
| Oct 21, 2025 | Parker Geoffrey M.47 | Chief Financial Officer | Sell | 36,744 | $1.26 | $46,168.84 | -2.8% | +24.6% | - | |
| Jun 10, 2025 | Messemer Deborah M.61 | Director | Sell | 36,885 | $1.42 | $52,376.70 | -25.6% | -21.9% | - | |
| Apr 21, 2025 | Yoshiyama Annie | SVP, Finance | Sell | 9,601 | $1.41 | $13,537.41 | -6.8% | -7.0% | - | |
| Mar 14, 2025 | Chang David D56 | President And CEO | Sell | 46,668 | $1.96 | $91,469.28 | -0.9% | -27.8% | +23.7% | |
| Mar 14, 2025 | Beneski Benjamin MacHinas | SVP, Chief Technical Officer | Sell | 5,488 | $1.98 | $10,838.80 | -2.5% | -27.8% | +23.7% | |
| Feb 18, 2025 | Messemer Deborah M.61 | Director | Sell | 13,313 | $2.43 | $32,350.59 | -8.4% | -61.6% | -20.1% | |
| Feb 3, 2025 | Douglas Earl Martin | SVP, General Counsel | Sell | 6,404 | $1.71 | $10,950.84 | -1.1% | -3.0% | +4.2% | |
| Feb 3, 2025 | Parker Geoffrey M.47 | Chief Financial Officer | Sell | 4,361 | $1.73 | $7,544.53 | -0.3% | -3.0% | +4.2% | |
| Feb 3, 2025 | Moore Timothy L. | Chief Technical Officer | Sell | 14,746 | $1.71 | $25,215.66 | -5.6% | -3.0% | +4.2% |